Scienture Holdings (SCNX)

• Market cap: $15.4M
• 1 day: -2.81%
• 5 days: -0.81%
• 1 month: -2.84%
• 3 months: -3.58%
• 6 months: -37.56%
• Year to date: -27.03%
• 1 year: -54.93%
• 5 years: -99.34%
• 10 years: -99.61%
• Sector: Healthcare
• Industry: Pharmaceutical Retailers

About: Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.

Employees: 9